nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—Cytochrome P450 3A4 Inducers—Carbamazepine—epilepsy syndrome	0.262	0.54	CiPCiCtD
Amprenavir—Cytochrome P450 3A4 Inducers—Topiramate—epilepsy syndrome	0.223	0.459	CiPCiCtD
Amprenavir—CYP2C19—epilepsy syndrome	0.0657	0.44	CbGaD
Amprenavir—CYP2D6—epilepsy syndrome	0.0487	0.326	CbGaD
Amprenavir—ABCB1—epilepsy syndrome	0.0348	0.233	CbGaD
Amprenavir—ABCC1—Phenobarbital—epilepsy syndrome	0.0104	0.0366	CbGbCtD
Amprenavir—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00853	0.03	CbGbCtD
Amprenavir—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00769	0.027	CbGbCtD
Amprenavir—CYP2B6—Clobazam—epilepsy syndrome	0.0074	0.026	CbGbCtD
Amprenavir—CYP2C8—Trimethadione—epilepsy syndrome	0.00687	0.0241	CbGbCtD
Amprenavir—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00646	0.0227	CbGbCtD
Amprenavir—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0062	0.0218	CbGbCtD
Amprenavir—CYP2B6—Carbamazepine—epilepsy syndrome	0.00613	0.0215	CbGbCtD
Amprenavir—CYP2C19—Trimethadione—epilepsy syndrome	0.00577	0.0202	CbGbCtD
Amprenavir—CYP2C19—Felbamate—epilepsy syndrome	0.00577	0.0202	CbGbCtD
Amprenavir—CYP2B6—Primidone—epilepsy syndrome	0.00572	0.0201	CbGbCtD
Amprenavir—CYP2B6—Phenytoin—epilepsy syndrome	0.0055	0.0193	CbGbCtD
Amprenavir—ABCB1—Levetiracetam—epilepsy syndrome	0.00547	0.0192	CbGbCtD
Amprenavir—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00542	0.019	CbGbCtD
Amprenavir—CYP2B6—Propofol—epilepsy syndrome	0.00513	0.018	CbGbCtD
Amprenavir—CYP2B6—Phenobarbital—epilepsy syndrome	0.0049	0.0172	CbGbCtD
Amprenavir—CYP2B6—Midazolam—epilepsy syndrome	0.00483	0.017	CbGbCtD
Amprenavir—CYP3A5—Carbamazepine—epilepsy syndrome	0.00483	0.017	CbGbCtD
Amprenavir—CYP2C9—Trimethadione—epilepsy syndrome	0.00479	0.0168	CbGbCtD
Amprenavir—CYP2C19—Clobazam—epilepsy syndrome	0.0047	0.0165	CbGbCtD
Amprenavir—CYP2B6—Diazepam—epilepsy syndrome	0.00465	0.0163	CbGbCtD
Amprenavir—CYP2C8—Carbamazepine—epilepsy syndrome	0.00464	0.0163	CbGbCtD
Amprenavir—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00451	0.0158	CbGbCtD
Amprenavir—CYP2C8—Primidone—epilepsy syndrome	0.00434	0.0152	CbGbCtD
Amprenavir—CYP3A5—Phenytoin—epilepsy syndrome	0.00433	0.0152	CbGbCtD
Amprenavir—CYP2C8—Phenytoin—epilepsy syndrome	0.00417	0.0146	CbGbCtD
Amprenavir—CYP2C19—Carbamazepine—epilepsy syndrome	0.0039	0.0137	CbGbCtD
Amprenavir—CYP2C8—Propofol—epilepsy syndrome	0.00388	0.0136	CbGbCtD
Amprenavir—CYP3A5—Phenobarbital—epilepsy syndrome	0.00386	0.0136	CbGbCtD
Amprenavir—CYP3A5—Midazolam—epilepsy syndrome	0.00381	0.0134	CbGbCtD
Amprenavir—ABCB1—Clobazam—epilepsy syndrome	0.00379	0.0133	CbGbCtD
Amprenavir—CYP2C8—Phenobarbital—epilepsy syndrome	0.00371	0.013	CbGbCtD
Amprenavir—CYP2B6—Valproic Acid—epilepsy syndrome	0.00366	0.0129	CbGbCtD
Amprenavir—CYP3A5—Diazepam—epilepsy syndrome	0.00366	0.0129	CbGbCtD
Amprenavir—ABCB1—Lamotrigine—epilepsy syndrome	0.00365	0.0128	CbGbCtD
Amprenavir—CYP2C19—Primidone—epilepsy syndrome	0.00364	0.0128	CbGbCtD
Amprenavir—CYP2C8—Diazepam—epilepsy syndrome	0.00352	0.0124	CbGbCtD
Amprenavir—CYP2C19—Phenytoin—epilepsy syndrome	0.00349	0.0123	CbGbCtD
Amprenavir—CYP2C19—Propofol—epilepsy syndrome	0.00326	0.0114	CbGbCtD
Amprenavir—CYP2C9—Carbamazepine—epilepsy syndrome	0.00324	0.0114	CbGbCtD
Amprenavir—ABCB1—Carbamazepine—epilepsy syndrome	0.00314	0.011	CbGbCtD
Amprenavir—CYP2C19—Phenobarbital—epilepsy syndrome	0.00311	0.0109	CbGbCtD
Amprenavir—CYP2C9—Primidone—epilepsy syndrome	0.00302	0.0106	CbGbCtD
Amprenavir—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.003	0.0105	CbGbCtD
Amprenavir—CYP2C19—Diazepam—epilepsy syndrome	0.00295	0.0104	CbGbCtD
Amprenavir—CYP2C9—Phenytoin—epilepsy syndrome	0.00291	0.0102	CbGbCtD
Amprenavir—CYP3A5—Valproic Acid—epilepsy syndrome	0.00289	0.0101	CbGbCtD
Amprenavir—CYP2C19—Zonisamide—epilepsy syndrome	0.00288	0.0101	CbGbCtD
Amprenavir—ABCB1—Phenytoin—epilepsy syndrome	0.00282	0.0099	CbGbCtD
Amprenavir—CYP3A4—Felbamate—epilepsy syndrome	0.00279	0.00979	CbGbCtD
Amprenavir—CYP3A4—Trimethadione—epilepsy syndrome	0.00279	0.00979	CbGbCtD
Amprenavir—CYP2C8—Valproic Acid—epilepsy syndrome	0.00277	0.00974	CbGbCtD
Amprenavir—CYP2C9—Propofol—epilepsy syndrome	0.00271	0.00951	CbGbCtD
Amprenavir—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00262	0.0092	CbGbCtD
Amprenavir—CYP2C9—Phenobarbital—epilepsy syndrome	0.00259	0.00909	CbGbCtD
Amprenavir—ABCB1—Phenobarbital—epilepsy syndrome	0.00251	0.00882	CbGbCtD
Amprenavir—ABCB1—Midazolam—epilepsy syndrome	0.00248	0.0087	CbGbCtD
Amprenavir—CYP2D6—Propofol—epilepsy syndrome	0.00248	0.0087	CbGbCtD
Amprenavir—CYP2C9—Diazepam—epilepsy syndrome	0.00245	0.00862	CbGbCtD
Amprenavir—ABCB1—Diazepam—epilepsy syndrome	0.00238	0.00836	CbGbCtD
Amprenavir—CYP3A4—Clonazepam—epilepsy syndrome	0.00237	0.00832	CbGbCtD
Amprenavir—CYP2C19—Valproic Acid—epilepsy syndrome	0.00233	0.00817	CbGbCtD
Amprenavir—CYP3A4—Clobazam—epilepsy syndrome	0.00227	0.00798	CbGbCtD
Amprenavir—CYP2C19—Topiramate—epilepsy syndrome	0.0021	0.00737	CbGbCtD
Amprenavir—CYP2C9—Valproic Acid—epilepsy syndrome	0.00193	0.00679	CbGbCtD
Amprenavir—CYP3A4—Rufinamide—epilepsy syndrome	0.00193	0.00678	CbGbCtD
Amprenavir—CYP3A4—Carbamazepine—epilepsy syndrome	0.00188	0.00661	CbGbCtD
Amprenavir—CYP3A4—Primidone—epilepsy syndrome	0.00176	0.00617	CbGbCtD
Amprenavir—CYP3A4—Phenytoin—epilepsy syndrome	0.00169	0.00593	CbGbCtD
Amprenavir—CYP3A4—Propofol—epilepsy syndrome	0.00158	0.00553	CbGbCtD
Amprenavir—CYP3A4—Phenobarbital—epilepsy syndrome	0.00151	0.00529	CbGbCtD
Amprenavir—CYP3A4—Acetazolamide—epilepsy syndrome	0.00151	0.00529	CbGbCtD
Amprenavir—CYP3A4—Midazolam—epilepsy syndrome	0.00148	0.00521	CbGbCtD
Amprenavir—CYP3A4—Diazepam—epilepsy syndrome	0.00143	0.00501	CbGbCtD
Amprenavir—CYP3A4—Zonisamide—epilepsy syndrome	0.00139	0.00489	CbGbCtD
Amprenavir—CYP3A4—Valproic Acid—epilepsy syndrome	0.00113	0.00395	CbGbCtD
Amprenavir—CYP3A4—Topiramate—epilepsy syndrome	0.00102	0.00356	CbGbCtD
Amprenavir—Anorexia—Lamotrigine—epilepsy syndrome	6.34e-05	0.001	CcSEcCtD
Amprenavir—Decreased appetite—Clonazepam—epilepsy syndrome	6.31e-05	0.000996	CcSEcCtD
Amprenavir—Gastrointestinal pain—Felbamate—epilepsy syndrome	6.29e-05	0.000994	CcSEcCtD
Amprenavir—Pruritus—Propofol—epilepsy syndrome	6.29e-05	0.000993	CcSEcCtD
Amprenavir—Abdominal pain—Diazepam—epilepsy syndrome	6.28e-05	0.000992	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	6.27e-05	0.00099	CcSEcCtD
Amprenavir—Decreased appetite—Phenytoin—epilepsy syndrome	6.27e-05	0.00099	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	6.27e-05	0.00099	CcSEcCtD
Amprenavir—Fatigue—Clonazepam—epilepsy syndrome	6.26e-05	0.000988	CcSEcCtD
Amprenavir—Cardiac disorder—Pregabalin—epilepsy syndrome	6.24e-05	0.000986	CcSEcCtD
Amprenavir—Asthenia—Midazolam—epilepsy syndrome	6.24e-05	0.000985	CcSEcCtD
Amprenavir—Decreased appetite—Oxcarbazepine—epilepsy syndrome	6.23e-05	0.000984	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	6.22e-05	0.000983	CcSEcCtD
Amprenavir—Fatigue—Phenytoin—epilepsy syndrome	6.22e-05	0.000982	CcSEcCtD
Amprenavir—Abdominal discomfort—Topiramate—epilepsy syndrome	6.21e-05	0.000981	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	6.19e-05	0.000978	CcSEcCtD
Amprenavir—Fatigue—Oxcarbazepine—epilepsy syndrome	6.18e-05	0.000976	CcSEcCtD
Amprenavir—Paraesthesia—Carbamazepine—epilepsy syndrome	6.18e-05	0.000976	CcSEcCtD
Amprenavir—Gastrointestinal pain—Zonisamide—epilepsy syndrome	6.16e-05	0.000973	CcSEcCtD
Amprenavir—Asthenia—Levetiracetam—epilepsy syndrome	6.16e-05	0.000972	CcSEcCtD
Amprenavir—Pruritus—Midazolam—epilepsy syndrome	6.15e-05	0.000971	CcSEcCtD
Amprenavir—Abdominal pain—Felbamate—epilepsy syndrome	6.08e-05	0.00096	CcSEcCtD
Amprenavir—Vomiting—Acetazolamide—epilepsy syndrome	6.08e-05	0.00096	CcSEcCtD
Amprenavir—Diarrhoea—Propofol—epilepsy syndrome	6.08e-05	0.00096	CcSEcCtD
Amprenavir—Pruritus—Levetiracetam—epilepsy syndrome	6.07e-05	0.000959	CcSEcCtD
Amprenavir—Tremor—Valproic Acid—epilepsy syndrome	6.07e-05	0.000958	CcSEcCtD
Amprenavir—Neutropenia—Topiramate—epilepsy syndrome	6.06e-05	0.000957	CcSEcCtD
Amprenavir—Connective tissue disorder—Gabapentin—epilepsy syndrome	6.06e-05	0.000957	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	6.06e-05	0.000957	CcSEcCtD
Amprenavir—Headache—Acetazolamide—epilepsy syndrome	5.99e-05	0.000946	CcSEcCtD
Amprenavir—Decreased appetite—Carbamazepine—epilepsy syndrome	5.98e-05	0.000945	CcSEcCtD
Amprenavir—Paraesthesia—Lamotrigine—epilepsy syndrome	5.97e-05	0.000943	CcSEcCtD
Amprenavir—Abdominal pain—Zonisamide—epilepsy syndrome	5.95e-05	0.00094	CcSEcCtD
Amprenavir—Asthenia—Fosphenytoin—epilepsy syndrome	5.94e-05	0.000939	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	5.94e-05	0.000938	CcSEcCtD
Amprenavir—Gastrointestinal pain—Clonazepam—epilepsy syndrome	5.94e-05	0.000937	CcSEcCtD
Amprenavir—Fatigue—Carbamazepine—epilepsy syndrome	5.93e-05	0.000937	CcSEcCtD
Amprenavir—Angioedema—Valproic Acid—epilepsy syndrome	5.92e-05	0.000934	CcSEcCtD
Amprenavir—Mental disorder—Pregabalin—epilepsy syndrome	5.89e-05	0.00093	CcSEcCtD
Amprenavir—Diarrhoea—Levetiracetam—epilepsy syndrome	5.87e-05	0.000927	CcSEcCtD
Amprenavir—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	5.86e-05	0.000926	CcSEcCtD
Amprenavir—Pruritus—Fosphenytoin—epilepsy syndrome	5.86e-05	0.000925	CcSEcCtD
Amprenavir—Malnutrition—Pregabalin—epilepsy syndrome	5.85e-05	0.000925	CcSEcCtD
Amprenavir—Hyperglycaemia—Topiramate—epilepsy syndrome	5.85e-05	0.000923	CcSEcCtD
Amprenavir—Erythema multiforme—Gabapentin—epilepsy syndrome	5.83e-05	0.000921	CcSEcCtD
Amprenavir—Asthenia—Vigabatrin—epilepsy syndrome	5.79e-05	0.000915	CcSEcCtD
Amprenavir—Decreased appetite—Lamotrigine—epilepsy syndrome	5.78e-05	0.000913	CcSEcCtD
Amprenavir—Flatulence—Pregabalin—epilepsy syndrome	5.77e-05	0.000911	CcSEcCtD
Amprenavir—Depression—Topiramate—epilepsy syndrome	5.76e-05	0.00091	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.74e-05	0.000907	CcSEcCtD
Amprenavir—Abdominal pain—Clonazepam—epilepsy syndrome	5.74e-05	0.000906	CcSEcCtD
Amprenavir—Fatigue—Lamotrigine—epilepsy syndrome	5.73e-05	0.000906	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	5.73e-05	0.000905	CcSEcCtD
Amprenavir—Cardiac disorder—Gabapentin—epilepsy syndrome	5.72e-05	0.000904	CcSEcCtD
Amprenavir—Pruritus—Vigabatrin—epilepsy syndrome	5.71e-05	0.000902	CcSEcCtD
Amprenavir—Asthenia—Diazepam—epilepsy syndrome	5.7e-05	0.000901	CcSEcCtD
Amprenavir—Nausea—Acetazolamide—epilepsy syndrome	5.68e-05	0.000897	CcSEcCtD
Amprenavir—Abdominal pain—Oxcarbazepine—epilepsy syndrome	5.67e-05	0.000895	CcSEcCtD
Amprenavir—Diarrhoea—Fosphenytoin—epilepsy syndrome	5.67e-05	0.000895	CcSEcCtD
Amprenavir—Vomiting—Propofol—epilepsy syndrome	5.65e-05	0.000892	CcSEcCtD
Amprenavir—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	5.63e-05	0.000889	CcSEcCtD
Amprenavir—Pruritus—Diazepam—epilepsy syndrome	5.62e-05	0.000888	CcSEcCtD
Amprenavir—Rash—Propofol—epilepsy syndrome	5.6e-05	0.000885	CcSEcCtD
Amprenavir—Dermatitis—Propofol—epilepsy syndrome	5.6e-05	0.000884	CcSEcCtD
Amprenavir—Headache—Propofol—epilepsy syndrome	5.57e-05	0.000879	CcSEcCtD
Amprenavir—Vomiting—Midazolam—epilepsy syndrome	5.53e-05	0.000873	CcSEcCtD
Amprenavir—Diarrhoea—Vigabatrin—epilepsy syndrome	5.52e-05	0.000872	CcSEcCtD
Amprenavir—Asthenia—Felbamate—epilepsy syndrome	5.52e-05	0.000872	CcSEcCtD
Amprenavir—Myalgia—Valproic Acid—epilepsy syndrome	5.51e-05	0.000871	CcSEcCtD
Amprenavir—Tremor—Pregabalin—epilepsy syndrome	5.49e-05	0.000866	CcSEcCtD
Amprenavir—Rash—Midazolam—epilepsy syndrome	5.48e-05	0.000865	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	5.48e-05	0.000865	CcSEcCtD
Amprenavir—Dermatitis—Midazolam—epilepsy syndrome	5.48e-05	0.000865	CcSEcCtD
Amprenavir—Vomiting—Levetiracetam—epilepsy syndrome	5.46e-05	0.000862	CcSEcCtD
Amprenavir—Discomfort—Valproic Acid—epilepsy syndrome	5.45e-05	0.00086	CcSEcCtD
Amprenavir—Headache—Midazolam—epilepsy syndrome	5.44e-05	0.00086	CcSEcCtD
Amprenavir—Pruritus—Felbamate—epilepsy syndrome	5.44e-05	0.00086	CcSEcCtD
Amprenavir—Abdominal pain—Carbamazepine—epilepsy syndrome	5.44e-05	0.000859	CcSEcCtD
Amprenavir—Diarrhoea—Diazepam—epilepsy syndrome	5.44e-05	0.000859	CcSEcCtD
Amprenavir—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.44e-05	0.000859	CcSEcCtD
Amprenavir—Rash—Levetiracetam—epilepsy syndrome	5.41e-05	0.000855	CcSEcCtD
Amprenavir—Dermatitis—Levetiracetam—epilepsy syndrome	5.41e-05	0.000854	CcSEcCtD
Amprenavir—Asthenia—Zonisamide—epilepsy syndrome	5.4e-05	0.000853	CcSEcCtD
Amprenavir—Mental disorder—Gabapentin—epilepsy syndrome	5.4e-05	0.000853	CcSEcCtD
Amprenavir—Headache—Levetiracetam—epilepsy syndrome	5.38e-05	0.000849	CcSEcCtD
Amprenavir—Malnutrition—Gabapentin—epilepsy syndrome	5.37e-05	0.000848	CcSEcCtD
Amprenavir—Angioedema—Pregabalin—epilepsy syndrome	5.35e-05	0.000845	CcSEcCtD
Amprenavir—Pruritus—Zonisamide—epilepsy syndrome	5.33e-05	0.000841	CcSEcCtD
Amprenavir—Flatulence—Gabapentin—epilepsy syndrome	5.29e-05	0.000835	CcSEcCtD
Amprenavir—Nausea—Propofol—epilepsy syndrome	5.28e-05	0.000833	CcSEcCtD
Amprenavir—Vomiting—Fosphenytoin—epilepsy syndrome	5.27e-05	0.000832	CcSEcCtD
Amprenavir—Diarrhoea—Felbamate—epilepsy syndrome	5.26e-05	0.000831	CcSEcCtD
Amprenavir—Abdominal pain—Lamotrigine—epilepsy syndrome	5.26e-05	0.00083	CcSEcCtD
Amprenavir—Rash—Fosphenytoin—epilepsy syndrome	5.22e-05	0.000825	CcSEcCtD
Amprenavir—Dermatitis—Fosphenytoin—epilepsy syndrome	5.22e-05	0.000824	CcSEcCtD
Amprenavir—Asthenia—Clonazepam—epilepsy syndrome	5.21e-05	0.000822	CcSEcCtD
Amprenavir—Headache—Fosphenytoin—epilepsy syndrome	5.19e-05	0.000819	CcSEcCtD
Amprenavir—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.18e-05	0.000818	CcSEcCtD
Amprenavir—Asthenia—Phenytoin—epilepsy syndrome	5.17e-05	0.000817	CcSEcCtD
Amprenavir—Nausea—Midazolam—epilepsy syndrome	5.16e-05	0.000815	CcSEcCtD
Amprenavir—Diarrhoea—Zonisamide—epilepsy syndrome	5.15e-05	0.000814	CcSEcCtD
Amprenavir—Asthenia—Oxcarbazepine—epilepsy syndrome	5.15e-05	0.000813	CcSEcCtD
Amprenavir—Pruritus—Clonazepam—epilepsy syndrome	5.14e-05	0.000811	CcSEcCtD
Amprenavir—Vomiting—Vigabatrin—epilepsy syndrome	5.13e-05	0.000811	CcSEcCtD
Amprenavir—Skin disorder—Valproic Acid—epilepsy syndrome	5.13e-05	0.000811	CcSEcCtD
Amprenavir—Pruritus—Phenytoin—epilepsy syndrome	5.1e-05	0.000805	CcSEcCtD
Amprenavir—Connective tissue disorder—Topiramate—epilepsy syndrome	5.1e-05	0.000805	CcSEcCtD
Amprenavir—Nausea—Levetiracetam—epilepsy syndrome	5.1e-05	0.000805	CcSEcCtD
Amprenavir—Rash—Vigabatrin—epilepsy syndrome	5.09e-05	0.000804	CcSEcCtD
Amprenavir—Dermatitis—Vigabatrin—epilepsy syndrome	5.09e-05	0.000803	CcSEcCtD
Amprenavir—Pruritus—Oxcarbazepine—epilepsy syndrome	5.07e-05	0.000801	CcSEcCtD
Amprenavir—Headache—Vigabatrin—epilepsy syndrome	5.06e-05	0.000799	CcSEcCtD
Amprenavir—Vomiting—Diazepam—epilepsy syndrome	5.05e-05	0.000798	CcSEcCtD
Amprenavir—Anorexia—Valproic Acid—epilepsy syndrome	5.04e-05	0.000796	CcSEcCtD
Amprenavir—Tremor—Gabapentin—epilepsy syndrome	5.03e-05	0.000794	CcSEcCtD
Amprenavir—Rash—Diazepam—epilepsy syndrome	5.01e-05	0.000792	CcSEcCtD
Amprenavir—Dermatitis—Diazepam—epilepsy syndrome	5.01e-05	0.000791	CcSEcCtD
Amprenavir—Myalgia—Pregabalin—epilepsy syndrome	4.98e-05	0.000787	CcSEcCtD
Amprenavir—Headache—Diazepam—epilepsy syndrome	4.98e-05	0.000786	CcSEcCtD
Amprenavir—Diarrhoea—Clonazepam—epilepsy syndrome	4.97e-05	0.000784	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.95e-05	0.000782	CcSEcCtD
Amprenavir—Asthenia—Carbamazepine—epilepsy syndrome	4.94e-05	0.00078	CcSEcCtD
Amprenavir—Diarrhoea—Phenytoin—epilepsy syndrome	4.93e-05	0.000779	CcSEcCtD
Amprenavir—Discomfort—Pregabalin—epilepsy syndrome	4.92e-05	0.000778	CcSEcCtD
Amprenavir—Nausea—Fosphenytoin—epilepsy syndrome	4.92e-05	0.000777	CcSEcCtD
Amprenavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.91e-05	0.000775	CcSEcCtD
Amprenavir—Erythema multiforme—Topiramate—epilepsy syndrome	4.91e-05	0.000775	CcSEcCtD
Amprenavir—Angioedema—Gabapentin—epilepsy syndrome	4.91e-05	0.000775	CcSEcCtD
Amprenavir—Vomiting—Felbamate—epilepsy syndrome	4.89e-05	0.000773	CcSEcCtD
Amprenavir—Pruritus—Carbamazepine—epilepsy syndrome	4.87e-05	0.000769	CcSEcCtD
Amprenavir—Rash—Felbamate—epilepsy syndrome	4.85e-05	0.000766	CcSEcCtD
Amprenavir—Dermatitis—Felbamate—epilepsy syndrome	4.85e-05	0.000765	CcSEcCtD
Amprenavir—Headache—Felbamate—epilepsy syndrome	4.82e-05	0.000761	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.82e-05	0.00076	CcSEcCtD
Amprenavir—Cardiac disorder—Topiramate—epilepsy syndrome	4.82e-05	0.00076	CcSEcCtD
Amprenavir—Nausea—Vigabatrin—epilepsy syndrome	4.8e-05	0.000757	CcSEcCtD
Amprenavir—Vomiting—Zonisamide—epilepsy syndrome	4.79e-05	0.000756	CcSEcCtD
Amprenavir—Asthenia—Lamotrigine—epilepsy syndrome	4.77e-05	0.000754	CcSEcCtD
Amprenavir—Rash—Zonisamide—epilepsy syndrome	4.75e-05	0.00075	CcSEcCtD
Amprenavir—Paraesthesia—Valproic Acid—epilepsy syndrome	4.75e-05	0.000749	CcSEcCtD
Amprenavir—Dermatitis—Zonisamide—epilepsy syndrome	4.74e-05	0.000749	CcSEcCtD
Amprenavir—Nausea—Diazepam—epilepsy syndrome	4.72e-05	0.000746	CcSEcCtD
Amprenavir—Headache—Zonisamide—epilepsy syndrome	4.72e-05	0.000745	CcSEcCtD
Amprenavir—Diarrhoea—Carbamazepine—epilepsy syndrome	4.71e-05	0.000744	CcSEcCtD
Amprenavir—Pruritus—Lamotrigine—epilepsy syndrome	4.71e-05	0.000743	CcSEcCtD
Amprenavir—Nervous system disorder—Pregabalin—epilepsy syndrome	4.69e-05	0.00074	CcSEcCtD
Amprenavir—Skin disorder—Pregabalin—epilepsy syndrome	4.64e-05	0.000733	CcSEcCtD
Amprenavir—Vomiting—Clonazepam—epilepsy syndrome	4.61e-05	0.000729	CcSEcCtD
Amprenavir—Decreased appetite—Valproic Acid—epilepsy syndrome	4.59e-05	0.000726	CcSEcCtD
Amprenavir—Vomiting—Phenytoin—epilepsy syndrome	4.58e-05	0.000724	CcSEcCtD
Amprenavir—Rash—Clonazepam—epilepsy syndrome	4.58e-05	0.000723	CcSEcCtD
Amprenavir—Dermatitis—Clonazepam—epilepsy syndrome	4.57e-05	0.000722	CcSEcCtD
Amprenavir—Myalgia—Gabapentin—epilepsy syndrome	4.57e-05	0.000722	CcSEcCtD
Amprenavir—Nausea—Felbamate—epilepsy syndrome	4.57e-05	0.000722	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.56e-05	0.000721	CcSEcCtD
Amprenavir—Vomiting—Oxcarbazepine—epilepsy syndrome	4.56e-05	0.00072	CcSEcCtD
Amprenavir—Fatigue—Valproic Acid—epilepsy syndrome	4.56e-05	0.00072	CcSEcCtD
Amprenavir—Anorexia—Pregabalin—epilepsy syndrome	4.55e-05	0.000719	CcSEcCtD
Amprenavir—Diarrhoea—Lamotrigine—epilepsy syndrome	4.55e-05	0.000719	CcSEcCtD
Amprenavir—Headache—Clonazepam—epilepsy syndrome	4.55e-05	0.000718	CcSEcCtD
Amprenavir—Rash—Phenytoin—epilepsy syndrome	4.55e-05	0.000718	CcSEcCtD
Amprenavir—Mental disorder—Topiramate—epilepsy syndrome	4.55e-05	0.000718	CcSEcCtD
Amprenavir—Dermatitis—Phenytoin—epilepsy syndrome	4.54e-05	0.000717	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.54e-05	0.000717	CcSEcCtD
Amprenavir—Rash—Oxcarbazepine—epilepsy syndrome	4.52e-05	0.000714	CcSEcCtD
Amprenavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.52e-05	0.000713	CcSEcCtD
Amprenavir—Headache—Phenytoin—epilepsy syndrome	4.52e-05	0.000713	CcSEcCtD
Amprenavir—Malnutrition—Topiramate—epilepsy syndrome	4.52e-05	0.000713	CcSEcCtD
Amprenavir—Discomfort—Gabapentin—epilepsy syndrome	4.52e-05	0.000713	CcSEcCtD
Amprenavir—Headache—Oxcarbazepine—epilepsy syndrome	4.49e-05	0.000709	CcSEcCtD
Amprenavir—Nausea—Zonisamide—epilepsy syndrome	4.47e-05	0.000706	CcSEcCtD
Amprenavir—Flatulence—Topiramate—epilepsy syndrome	4.45e-05	0.000703	CcSEcCtD
Amprenavir—Vomiting—Carbamazepine—epilepsy syndrome	4.38e-05	0.000691	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.35e-05	0.000687	CcSEcCtD
Amprenavir—Rash—Carbamazepine—epilepsy syndrome	4.34e-05	0.000685	CcSEcCtD
Amprenavir—Dermatitis—Carbamazepine—epilepsy syndrome	4.34e-05	0.000685	CcSEcCtD
Amprenavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.32e-05	0.000682	CcSEcCtD
Amprenavir—Nausea—Clonazepam—epilepsy syndrome	4.31e-05	0.000681	CcSEcCtD
Amprenavir—Headache—Carbamazepine—epilepsy syndrome	4.31e-05	0.000681	CcSEcCtD
Amprenavir—Nervous system disorder—Gabapentin—epilepsy syndrome	4.3e-05	0.000679	CcSEcCtD
Amprenavir—Paraesthesia—Pregabalin—epilepsy syndrome	4.29e-05	0.000678	CcSEcCtD
Amprenavir—Nausea—Phenytoin—epilepsy syndrome	4.28e-05	0.000676	CcSEcCtD
Amprenavir—Nausea—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000673	CcSEcCtD
Amprenavir—Skin disorder—Gabapentin—epilepsy syndrome	4.26e-05	0.000672	CcSEcCtD
Amprenavir—Tremor—Topiramate—epilepsy syndrome	4.23e-05	0.000668	CcSEcCtD
Amprenavir—Vomiting—Lamotrigine—epilepsy syndrome	4.23e-05	0.000668	CcSEcCtD
Amprenavir—Rash—Lamotrigine—epilepsy syndrome	4.19e-05	0.000662	CcSEcCtD
Amprenavir—Dermatitis—Lamotrigine—epilepsy syndrome	4.19e-05	0.000662	CcSEcCtD
Amprenavir—Abdominal pain—Valproic Acid—epilepsy syndrome	4.18e-05	0.00066	CcSEcCtD
Amprenavir—Anorexia—Gabapentin—epilepsy syndrome	4.18e-05	0.00066	CcSEcCtD
Amprenavir—Headache—Lamotrigine—epilepsy syndrome	4.17e-05	0.000658	CcSEcCtD
Amprenavir—Decreased appetite—Pregabalin—epilepsy syndrome	4.15e-05	0.000656	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.13e-05	0.000651	CcSEcCtD
Amprenavir—Fatigue—Pregabalin—epilepsy syndrome	4.12e-05	0.000651	CcSEcCtD
Amprenavir—Nausea—Carbamazepine—epilepsy syndrome	4.09e-05	0.000646	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.99e-05	0.00063	CcSEcCtD
Amprenavir—Nausea—Lamotrigine—epilepsy syndrome	3.95e-05	0.000624	CcSEcCtD
Amprenavir—Paraesthesia—Gabapentin—epilepsy syndrome	3.93e-05	0.000621	CcSEcCtD
Amprenavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.91e-05	0.000617	CcSEcCtD
Amprenavir—Myalgia—Topiramate—epilepsy syndrome	3.85e-05	0.000607	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.82e-05	0.000603	CcSEcCtD
Amprenavir—Decreased appetite—Gabapentin—epilepsy syndrome	3.81e-05	0.000601	CcSEcCtD
Amprenavir—Discomfort—Topiramate—epilepsy syndrome	3.8e-05	0.0006	CcSEcCtD
Amprenavir—Asthenia—Valproic Acid—epilepsy syndrome	3.79e-05	0.000599	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.78e-05	0.000597	CcSEcCtD
Amprenavir—Fatigue—Gabapentin—epilepsy syndrome	3.78e-05	0.000597	CcSEcCtD
Amprenavir—Abdominal pain—Pregabalin—epilepsy syndrome	3.78e-05	0.000596	CcSEcCtD
Amprenavir—Pruritus—Valproic Acid—epilepsy syndrome	3.74e-05	0.00059	CcSEcCtD
Amprenavir—Diarrhoea—Valproic Acid—epilepsy syndrome	3.62e-05	0.000571	CcSEcCtD
Amprenavir—Nervous system disorder—Topiramate—epilepsy syndrome	3.61e-05	0.000571	CcSEcCtD
Amprenavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.58e-05	0.000566	CcSEcCtD
Amprenavir—Skin disorder—Topiramate—epilepsy syndrome	3.58e-05	0.000565	CcSEcCtD
Amprenavir—Anorexia—Topiramate—epilepsy syndrome	3.51e-05	0.000555	CcSEcCtD
Amprenavir—Abdominal pain—Gabapentin—epilepsy syndrome	3.46e-05	0.000547	CcSEcCtD
Amprenavir—Asthenia—Pregabalin—epilepsy syndrome	3.43e-05	0.000541	CcSEcCtD
Amprenavir—Pruritus—Pregabalin—epilepsy syndrome	3.38e-05	0.000534	CcSEcCtD
Amprenavir—Vomiting—Valproic Acid—epilepsy syndrome	3.36e-05	0.000531	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.36e-05	0.00053	CcSEcCtD
Amprenavir—Rash—Valproic Acid—epilepsy syndrome	3.33e-05	0.000526	CcSEcCtD
Amprenavir—Dermatitis—Valproic Acid—epilepsy syndrome	3.33e-05	0.000526	CcSEcCtD
Amprenavir—Headache—Valproic Acid—epilepsy syndrome	3.31e-05	0.000523	CcSEcCtD
Amprenavir—Paraesthesia—Topiramate—epilepsy syndrome	3.31e-05	0.000523	CcSEcCtD
Amprenavir—Diarrhoea—Pregabalin—epilepsy syndrome	3.27e-05	0.000516	CcSEcCtD
Amprenavir—Decreased appetite—Topiramate—epilepsy syndrome	3.2e-05	0.000506	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.18e-05	0.000503	CcSEcCtD
Amprenavir—Fatigue—Topiramate—epilepsy syndrome	3.18e-05	0.000502	CcSEcCtD
Amprenavir—Asthenia—Gabapentin—epilepsy syndrome	3.14e-05	0.000496	CcSEcCtD
Amprenavir—Nausea—Valproic Acid—epilepsy syndrome	3.14e-05	0.000496	CcSEcCtD
Amprenavir—Pruritus—Gabapentin—epilepsy syndrome	3.1e-05	0.00049	CcSEcCtD
Amprenavir—Vomiting—Pregabalin—epilepsy syndrome	3.04e-05	0.00048	CcSEcCtD
Amprenavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.01e-05	0.000476	CcSEcCtD
Amprenavir—Rash—Pregabalin—epilepsy syndrome	3.01e-05	0.000476	CcSEcCtD
Amprenavir—Dermatitis—Pregabalin—epilepsy syndrome	3.01e-05	0.000475	CcSEcCtD
Amprenavir—Diarrhoea—Gabapentin—epilepsy syndrome	3e-05	0.000473	CcSEcCtD
Amprenavir—Headache—Pregabalin—epilepsy syndrome	2.99e-05	0.000473	CcSEcCtD
Amprenavir—Abdominal pain—Topiramate—epilepsy syndrome	2.91e-05	0.00046	CcSEcCtD
Amprenavir—Nausea—Pregabalin—epilepsy syndrome	2.84e-05	0.000448	CcSEcCtD
Amprenavir—Vomiting—Gabapentin—epilepsy syndrome	2.79e-05	0.00044	CcSEcCtD
Amprenavir—Rash—Gabapentin—epilepsy syndrome	2.76e-05	0.000436	CcSEcCtD
Amprenavir—Dermatitis—Gabapentin—epilepsy syndrome	2.76e-05	0.000436	CcSEcCtD
Amprenavir—Headache—Gabapentin—epilepsy syndrome	2.74e-05	0.000433	CcSEcCtD
Amprenavir—Asthenia—Topiramate—epilepsy syndrome	2.64e-05	0.000418	CcSEcCtD
Amprenavir—Pruritus—Topiramate—epilepsy syndrome	2.61e-05	0.000412	CcSEcCtD
Amprenavir—Nausea—Gabapentin—epilepsy syndrome	2.6e-05	0.000411	CcSEcCtD
Amprenavir—Diarrhoea—Topiramate—epilepsy syndrome	2.52e-05	0.000398	CcSEcCtD
Amprenavir—Vomiting—Topiramate—epilepsy syndrome	2.34e-05	0.00037	CcSEcCtD
Amprenavir—Rash—Topiramate—epilepsy syndrome	2.32e-05	0.000367	CcSEcCtD
Amprenavir—Dermatitis—Topiramate—epilepsy syndrome	2.32e-05	0.000367	CcSEcCtD
Amprenavir—Headache—Topiramate—epilepsy syndrome	2.31e-05	0.000365	CcSEcCtD
Amprenavir—Nausea—Topiramate—epilepsy syndrome	2.19e-05	0.000346	CcSEcCtD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.62e-06	0.000199	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	3.61e-06	0.000199	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	3.61e-06	0.000198	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FYN—epilepsy syndrome	3.6e-06	0.000198	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.59e-06	0.000197	CbGpPWpGaD
Amprenavir—ABCC1—Disease—H2AFX—epilepsy syndrome	3.58e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.58e-06	0.000197	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADSL—epilepsy syndrome	3.54e-06	0.000194	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.52e-06	0.000193	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.51e-06	0.000193	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.5e-06	0.000192	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GLUL—epilepsy syndrome	3.47e-06	0.000191	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	3.46e-06	0.00019	CbGpPWpGaD
Amprenavir—ABCC1—Disease—YWHAZ—epilepsy syndrome	3.46e-06	0.00019	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.44e-06	0.000189	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	3.41e-06	0.000187	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	3.41e-06	0.000187	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	3.4e-06	0.000187	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	3.38e-06	0.000186	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	3.37e-06	0.000185	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AQP1—epilepsy syndrome	3.36e-06	0.000185	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.36e-06	0.000185	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.34e-06	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.34e-06	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.34e-06	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.34e-06	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.34e-06	0.000183	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.33e-06	0.000183	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CCR5—epilepsy syndrome	3.33e-06	0.000183	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—HMOX1—epilepsy syndrome	3.31e-06	0.000182	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AQP1—epilepsy syndrome	3.28e-06	0.00018	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	3.28e-06	0.00018	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CAT—epilepsy syndrome	3.26e-06	0.000179	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.23e-06	0.000177	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.2e-06	0.000176	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	3.2e-06	0.000176	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.18e-06	0.000175	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	3.18e-06	0.000175	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ABCB1—epilepsy syndrome	3.17e-06	0.000174	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.17e-06	0.000174	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.16e-06	0.000173	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.12e-06	0.000172	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.11e-06	0.000171	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.1e-06	0.000171	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TSC2—epilepsy syndrome	3.09e-06	0.00017	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.09e-06	0.00017	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.06e-06	0.000168	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.05e-06	0.000168	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.05e-06	0.000168	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.05e-06	0.000168	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.04e-06	0.000167	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.04e-06	0.000167	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APOE—epilepsy syndrome	3.03e-06	0.000166	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3e-06	0.000165	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CHRM3—epilepsy syndrome	2.97e-06	0.000163	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	2.97e-06	0.000163	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GPX1—epilepsy syndrome	2.95e-06	0.000162	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.94e-06	0.000162	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.94e-06	0.000161	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	2.87e-06	0.000158	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6ST—epilepsy syndrome	2.84e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.84e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.84e-06	0.000156	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.83e-06	0.000156	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS2—epilepsy syndrome	2.82e-06	0.000155	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.8e-06	0.000154	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.8e-06	0.000154	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.8e-06	0.000154	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.78e-06	0.000153	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.77e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.77e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.77e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	2.73e-06	0.00015	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—BCHE—epilepsy syndrome	2.72e-06	0.000149	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.71e-06	0.000149	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.69e-06	0.000148	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.67e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.67e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.67e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.66e-06	0.000146	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.59e-06	0.000143	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	2.59e-06	0.000142	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AGT—epilepsy syndrome	2.59e-06	0.000142	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.58e-06	0.000142	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	2.56e-06	0.000141	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TH—epilepsy syndrome	2.55e-06	0.00014	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—APOE—epilepsy syndrome	2.53e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.53e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.53e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.53e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.53e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.51e-06	0.000138	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TH—epilepsy syndrome	2.5e-06	0.000137	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.48e-06	0.000136	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.43e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.43e-06	0.000133	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.42e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.41e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.41e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.4e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.38e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.36e-06	0.00013	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.36e-06	0.00013	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.34e-06	0.000129	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.31e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.31e-06	0.000127	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.3e-06	0.000126	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGF2—epilepsy syndrome	2.3e-06	0.000126	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.28e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.27e-06	0.000125	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.26e-06	0.000124	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.23e-06	0.000123	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.23e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.22e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.21e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.2e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.19e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.19e-06	0.00012	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—POMC—epilepsy syndrome	2.18e-06	0.00012	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.17e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.17e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.17e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.17e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TH—epilepsy syndrome	2.16e-06	0.000119	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	2.13e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.13e-06	0.000117	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.11e-06	0.000116	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CAT—epilepsy syndrome	2.1e-06	0.000116	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTOR—epilepsy syndrome	2.09e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.08e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.08e-06	0.000114	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—epilepsy syndrome	2.07e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.06e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.06e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.05e-06	0.000113	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	2.05e-06	0.000112	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.02e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.02e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.01e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—BCHE—epilepsy syndrome	2e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2e-06	0.00011	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALB—epilepsy syndrome	1.98e-06	0.000109	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.98e-06	0.000109	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.97e-06	0.000109	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.96e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.94e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TH—epilepsy syndrome	1.93e-06	0.000106	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.91e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.9e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.9e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.9e-06	0.000104	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.89e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.89e-06	0.000104	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TH—epilepsy syndrome	1.88e-06	0.000104	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.88e-06	0.000103	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.87e-06	0.000103	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.86e-06	0.000102	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.83e-06	0.0001	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.83e-06	0.0001	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.8e-06	9.92e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.8e-06	9.9e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.79e-06	9.82e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.78e-06	9.79e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.78e-06	9.79e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TH—epilepsy syndrome	1.78e-06	9.76e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.77e-06	9.71e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TH—epilepsy syndrome	1.76e-06	9.67e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—epilepsy syndrome	1.74e-06	9.54e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.73e-06	9.52e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.73e-06	9.52e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SRC—epilepsy syndrome	1.68e-06	9.22e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.67e-06	9.17e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.63e-06	8.98e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.63e-06	8.96e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.61e-06	8.85e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.61e-06	8.85e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.6e-06	8.78e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.59e-06	8.74e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.57e-06	8.64e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAT—epilepsy syndrome	1.55e-06	8.53e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.55e-06	8.5e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.49e-06	8.19e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.48e-06	8.14e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.47e-06	8.07e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.46e-06	8.04e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.45e-06	7.98e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.45e-06	7.97e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.44e-06	7.93e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.44e-06	7.9e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.42e-06	7.82e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.41e-06	7.76e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.41e-06	7.75e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—POMC—epilepsy syndrome	1.4e-06	7.72e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.4e-06	7.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.38e-06	7.61e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.37e-06	7.54e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.32e-06	7.27e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.31e-06	7.2e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.3e-06	7.16e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—epilepsy syndrome	1.28e-06	7.04e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.26e-06	6.93e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.25e-06	6.88e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.24e-06	6.81e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.24e-06	6.79e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.23e-06	6.79e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AGT—epilepsy syndrome	1.23e-06	6.76e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—APOE—epilepsy syndrome	1.21e-06	6.63e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.19e-06	6.53e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.18e-06	6.47e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.16e-06	6.4e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TH—epilepsy syndrome	1.16e-06	6.38e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.16e-06	6.37e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.15e-06	6.32e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.14e-06	6.24e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.13e-06	6.19e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	1.12e-06	6.16e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.09e-06	6.02e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.08e-06	5.96e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.06e-06	5.83e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—epilepsy syndrome	1.04e-06	5.73e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—POMC—epilepsy syndrome	1.04e-06	5.69e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.76e-07	5.36e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.69e-07	5.32e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—POMC—epilepsy syndrome	9.67e-07	5.32e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—epilepsy syndrome	9.67e-07	5.32e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.56e-07	5.25e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	9.48e-07	5.21e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—epilepsy syndrome	9.44e-07	5.19e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.3e-07	5.11e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.9e-07	4.89e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—epilepsy syndrome	8.82e-07	4.85e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—epilepsy syndrome	8.73e-07	4.8e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.64e-07	4.75e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	8.46e-07	4.65e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.26e-07	4.54e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.78e-07	4.28e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.72e-07	4.24e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.58e-07	4.17e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.43e-07	4.08e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.38e-07	3.51e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.82e-07	3.2e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—epilepsy syndrome	5.63e-07	3.09e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.5e-07	3.02e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.09e-07	2.8e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—epilepsy syndrome	4.77e-07	2.62e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.25e-07	2.34e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.15e-07	2.28e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.91e-07	2.15e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.88e-07	2.13e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.56e-07	1.41e-05	CbGpPWpGaD
